You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
The Office for Human Research Protections last week concluded that a controversial study involving patients with serious respiratory problems has not needlessly endangered subjects. Researchers may be able to restart a suspended portion of the trial if they improve patient consent practices and provide more information to review boards.
